FDA Commissioner on Lowering Drug Prices, AI Integration, and Healthcare Costs

Executive Order to Reduce Drug Prices

• 🎯 President Trump's executive order aims to reduce prescription drug prices by 50-90% by cutting out middlemen and ensuring Americans pay prices similar to other wealthy countries.
• 💡 The order seeks to transform non-competitive healthcare markets into competitive ones, addressing the "great American ripoff" where companies charge Americans significantly more than elsewhere.
• 💰 The administration will leverage the power of the federal government, including the DOJ and Medicare/Medicaid, to enforce price restrictions if necessary.

Middlemen and Healthcare Costs

• 🧩 The high cost of drugs is attributed to multiple stakeholders, including middlemen and hospitals, marking up prices and sometimes building kickbacks into the cost.
• 📉 Public trust in the healthcare system is at an all-time low, with many in the sector getting wealthy while the American worker bears the burden through paycheck deductions.
• ⚠️ Doctors are witnessing patients being financially ruined by healthcare costs, a situation that contradicts the physician's oath to care for patients.

FDA Modernization and AI Integration

• 🚀 The FDA is modernizing its processes, including integrating Artificial Intelligence (AI) into decision-making to accelerate drug reviews and approvals.
• ⏱️ An AI-assisted scientific review took only six minutes for a task that would normally take a human reviewer two to three days, highlighting AI's potential to speed up the process.
• ✅ The FDA has an aggressive plan to implement AI-assisted reviews agency-wide by midsummer and is also reducing requirements like animal testing in favor of more predictive methods like computational modeling.
• 🛠️ Deregulation and cutting red tape are key to getting drugs approved quicker and promoting American inventors and developers.